Salvatore Petta
Salvatore Petta
Ricercatore di Gastroenterologia, Universitā di Palermo
Verified email at - Homepage
Cited by
Cited by
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis
E Villa, C Cammā, M Marietta, M Luongo, R Critelli, S Colopi, C Tata, ...
Gastroenterology 143 (5), 1253-1260. e4, 2012
EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)
CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ...
Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C
S Petta, C Cammā, C Scazzone, C Tripodo, V Di Marco, A Bono, D Cabibi, ...
Hepatology 51 (4), 1158-1167, 2010
Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ...
Journal of hepatology 69 (4), 896-904, 2018
Non-alcoholic fatty liver disease pathogenesis: the present and the future
S Petta, C Muratore, A Craxi
Digestive and Liver Disease 41 (9), 615-625, 2009
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Statin use and non-alcoholic steatohepatitis in at risk individuals
P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ...
Journal of hepatology 63 (3), 705-712, 2015
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis
S McPherson, T Hardy, JF Dufour, S Petta, M Romero-Gomez, M Allison, ...
The American journal of gastroenterology 112 (5), 740, 2017
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C
L Rizzo, V Calvaruso, B Cacopardo, N Alessi, M Attanasio, S Petta, ...
American Journal of Gastroenterology 106 (12), 2112-2120, 2011
Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
G Marchesini, S Petta, R Dalle Grave
Hepatology 63 (6), 2032-2043, 2016
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ...
Digestive and Liver Disease 49 (5), 471-483, 2017
Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies
S Petta, M Maida, FS Macaluso, M Barbara, A Licata, A Craxė, C Cammā
Gastroenterology 150 (1), 145-155. e4, 2016
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection
S Petta, C Camma, V Di Marco, N Alessi, D Cabibi, R Caldarella, A Licata, ...
American Journal of Gastroenterology 103 (5), 1136-1144, 2008
Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents
V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinč, ...
Gastroenterology 155 (2), 411-421. e4, 2018
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
S Petta, M Maida, FS Macaluso, V Di Marco, C Camma, D Cabibi, A Craxė
Hepatology 62 (4), 1101-1110, 2015
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation …
S Petta, VWS Wong, C Cammā, JB Hiriart, GLH Wong, F Marra, J Vergniol, ...
Hepatology 65 (4), 1145-1155, 2017
Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation
ZM Younossi, G Marchesini, H Pinto-Cortez, S Petta
Transplantation 103 (1), 22-27, 2019
Hyperuricemia is associated with histological liver damage in patients with non‐alcoholic fatty liver disease
S Petta, C Cammā, D Cabibi, V Di Marco, A Craxė
Alimentary pharmacology & therapeutics 34 (7), 757-766, 2011
The system can't perform the operation now. Try again later.
Articles 1–20